Ana Carrizosa Anderson

14PUBLICATIONS
42CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersHaematological tumoursTissue engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Sep 05, 2025
Loss-of-function mutations ensure that response to immune checkpoint therapy is NOD2 be denied.

Ana C Anderson, Manu Rangachari

|Jul 09, 2025
Therapeutic potential of targeting LAG-3 in cancer.

Diwakar Davar, Ana Carrizosa Anderson, Ivan Diaz-Padilla

|Jun 20, 2024
Challenges and opportunities in cancer immunotherapy: a Society for Immunotherapy of Cancer (SITC) strategic vision.

Leisha A Emens, Pedro J Romero, Ana Carrizosa Anderson

|Jan 19, 2024
Decoding T cell state-specific regulomes in cancer.

Giulia Escobar, Ana C Anderson

|Oct 12, 2023
Targeting PGLYRP1 promotes antitumor immunity while inhibiting autoimmune neuroinflammation.

Alexandra Schnell, Linglin Huang, Brianna M L Regan

|Jul 20, 2023
γδ T cell dichotomy with opposing cytotoxic and wound healing functions in human solid tumors.

Cathal Harmon, Alexandra Zaborowski, Haim Moore

Pageof 3

Frequent Collaborators

3 joint publications

Vijay K Kuchroo

2 joint publications

Davide Mangani

2 joint publications

Karen O Dixon

2 joint publications

Orit Rozenblatt-Rosen